- Home
- OABI vs BETR Comparison
OABI vs BETR Comparison
Compare OABI & BETR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OABI
- BETR
- Stock Information
- Founded
- OABI 2012
- BETR 2014
- Country
- OABI United States
- BETR United States
- Employees
- OABI N/A
- BETR N/A
- Industry
- OABI Biotechnology: Pharmaceutical Preparations
- BETR Finance: Consumer Services
- Sector
- OABI Health Care
- BETR Finance
- Exchange
- OABI Nasdaq
- BETR Nasdaq
- Market Cap
- OABI 198.2M
- BETR 218.6M
- IPO Year
- OABI N/A
- BETR N/A
- Fundamental
- Price
- OABI $1.93
- BETR $12.91
- Analyst Decision
- OABI Strong Buy
- BETR
- Analyst Count
- OABI 3
- BETR 0
- Target Price
- OABI $7.00
- BETR N/A
- AVG Volume (30 Days)
- OABI 912.8K
- BETR 119.5K
- Earning Date
- OABI 08-07-2025
- BETR 08-07-2025
- Dividend Yield
- OABI N/A
- BETR N/A
- EPS Growth
- OABI N/A
- BETR N/A
- EPS
- OABI N/A
- BETR N/A
- Revenue
- OABI $26,744,000.00
- BETR $118,790,000.00
- Revenue This Year
- OABI N/A
- BETR N/A
- Revenue Next Year
- OABI $45.65
- BETR N/A
- P/E Ratio
- OABI N/A
- BETR N/A
- Revenue Growth
- OABI 27.07
- BETR 56.38
- 52 Week Low
- OABI $1.22
- BETR $7.71
- 52 Week High
- OABI $4.96
- BETR $30.00
- Technical
- Relative Strength Index (RSI)
- OABI 69.01
- BETR 50.31
- Support Level
- OABI $1.55
- BETR $11.90
- Resistance Level
- OABI $1.73
- BETR $13.44
- Average True Range (ATR)
- OABI 0.10
- BETR 0.78
- MACD
- OABI 0.03
- BETR -0.03
- Stochastic Oscillator
- OABI 100.00
- BETR 34.00
About OABI OmniAb Inc.
OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.
About BETR Better Home & Finance Holding Company
Better Home & Finance Holding Co is a digital-first homeownership company whose services include mortgage, real estate, title, and homeowners insurance. The company has combined technology innovation and fresh thinking with a deep customer focus with the goal of revolutionizing the homeownership industry.